Rh
NYSE:RHSpecialty Retail
+$7.55 today
- Market cap
- $2.22B
- Beta
- 1.90
- P/E (TTM)
- 26.2
- EPS (TTM)
- $5.47
Volume 0.68M
Average 1.22M
RH Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
RhNYSE: RH
Gross Profit · Q2 FY2026 · quarter ended Aug 2026
Gross profit growth accelerates
Q2 FY2026 gross profit of $444.85M rose 8.7% year over year, ahead of the +2.6% change in trailing-twelve-month gross profit. Sequentially, it rose 34.3% from the prior quarter. Over 3 fiscal years it compounded at -5.8% a year.
Context
- Gross profit amounted to 44.1% of revenue in FY2025, down 0.4 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +8.7% holds above the trailing-twelve-month pace of +2.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 1.52B USD
- Year-over-year change
- +7.1%
- 4-year CAGR
- -4.9%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | 1.52B | +7.1% |
| FY2024 | 2025-01-31 | 1.41B | +1.9% |
| FY2023 | 2024-01-31 | 1.39B | -23.3% |
| FY2022 | 2023-01-31 | 1.81B | -2.3% |
| FY2021 | 2022-01-31 | 1.86B | — |
Gross Profit vs competitors
How RH compares with its peers on the latest reported figures
- RH's LTM Aug 2026 gross profit of $1.53B is the 6th highest of the 11 companies compared; the peer median is $1.63B.
- Its year-over-year change of +2.6% is the 8th highest of 11, against a peer median of +7.0%.
- Gross profit amounts to 44.3% of revenue for RH, versus a peer median of 37.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $3.87B | +20.4% | -4.1% | 45.0% | |
| LTM Aug 2026 | $3.36B | +5.0% | +15.4% | 62.9% | |
| LTM May 2026 | $2.5B | +10.7% | +1.9% | 36.9% | |
| LTM Aug 2026 | $2.22B | +9.0% | -1.6% | 35.8% | |
| LTM Aug 2026 | $2.12B | +22.3% | +5.5% | 37.2% | |
| LTM Aug 2026 | $1.53B | +2.6% | -5.8% | 44.3% | |
| LTM Jun 2026 | $1.14B | -7.5% | -0.5% | 56.7% | |
| LTM Jun 2026 | $982.56M | -31.2% | -14.1% | 23.9% | |
| LTM Sep 2026 | $917M | +3.3% | -4.9% | 23.3% | |
| LTM Sep 2026 | $910.72M | +11.5% | +8.3% | 91.6% | |
| LTM Sep 2026 | $870.28M | -21.3% | -0.9% | 20.7% | |
| Peer median (excluding RH) | $1.63B | +7.0% | -0.7% | 37.1% | |
Competitors are the stored peer set for RH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Jan 2024 | FY2024 Jan 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 3.76B | 3.59B | 3.03B | 3.18B | 3.44B |
| Cost of Revenue | 1.9B | 1.78B | 1.64B | 1.77B | 1.92B |
| Gross Profit | 1.86B | 1.81B | 1.39B | 1.41B | 1.52B |
| Gross Margin | 49.4% | 50.5% | 45.9% | 44.5% | 44.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 922.34M | 1.07B | 1.03B | 1.05B | 1.13B |
| Operating Expenses | 922.34M | 1.07B | 1.03B | 1.05B | 1.13B |
| Depreciation & Amortization | 168.5M | 183.77M | 118.99M | 130.19M | 148.5M |
| EBITDA | 1.07B | 774.84M | 523.59M | 453.28M | 540.82M |
| EBITDA Margin | 28.4% | 21.6% | 17.3% | 14.3% | 15.7% |
| Operating Income | 933.08M | 746.08M | 363.18M | 367.76M | 387.27M |
| Operating Margin | 24.8% | 20.8% | 12.0% | 11.6% | 11.3% |
| Interest Income | 1.94M | 38.52M | 39.6M | 3.9M | 0 |
| Interest Expense | 66.88M | 151.73M | 237.9M | 234.5M | 225.38M |
| Other Income / Expenses | (110.97M) | (308.79M) | (207.36M) | (290.54M) | (220.33M) |
| Income Before Tax | 822.1M | 437.28M | 155.82M | 77.21M | 166.94M |
| Pre-Tax Margin | 21.9% | 12.2% | 5.1% | 2.4% | 4.9% |
| Income Tax Expense | 133.56M | (91.36M) | 28.26M | 4.8M | 42.15M |
| Net Income | 688.55M | 528.64M | 127.56M | 72.41M | 124.79M |
| Net Margin | 18.3% | 14.7% | 4.2% | 2.3% | 3.6% |
| EPS (Basic) | 32.37 | 22.47 | 6.42 | 3.92 | 6.65 |
| EPS (Diluted) | 22.13 | 19.90 | 5.91 | 3.62 | 6.31 |
| Weighted Avg Shares | 21.27M | 23.52M | 19.88M | 18.49M | 18.75M |
| Weighted Avg Shares (Diluted) | 31.11M | 26.56M | 21.6M | 19.99M | 19.79M |
Rh
NYSE:RH
Intrinsic Alpha fair value
Locked
Current Price
$117.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.